Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$13.45 USD
-1.18 (-8.07%)
Updated May 17, 2024 04:00 PM ET
After-Market: $13.42 -0.03 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
Viridian Therapeutics, Inc. [VRDN]
Reports for Purchase
Showing records 1 - 20 ( 84 total )
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
TED KOL Check: Untangling The TED Therapeutic Landscape
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
INVITE: TED KOL Check -- Untangling The TED Therapeutic Landscape
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Make Sure To Read Fine Print; Lonigutamab Update/Read Through To VRDN
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Continues to THRIVE --- Awaiting Pivotal Data By Mid-2024
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Kickstart or False Start? What January Tells Us about Biotech Annual Returns
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Target In Sight: New Horizon For VRDN With VRDN-003 Nomination
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The TED Trifecta: Setting the Stage Ahead of SC TED Strategic Update
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VRDN 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Execution Can Be A Beautiful Thing; Pipeline Efforts On Track
Provider: Wedbush Securities Inc.
Analyst: CHICO L